BusinessPraxis Bioresearch Announces Peer-Reviewed Publication of Positive Data for Novel Prodrug Stimulant with Abuse-Deterrent PropertiesBy Nasdaq OMXMar 28, 2018, 12:05 PM UTC
BusinessPraxis Bioresearch Presents Positive Preclinical Data for Novel Prodrug Stimulant with Abuse-Deterrent Properties at ACNP Annual MeetingBy Nasdaq OMXDec 7, 2017, 12:35 PM UTC